Cargando…
Willingness to use novel reversible methods of male birth control: a community-based survey of cisgender men in the United States
BACKGROUND: There is high global demand for new methods of male birth control (MBC). However, contemporary evidence regarding men’s method-specific attitudes and their determinants is sparse. METHODS: Non-sterilized cisgender men ages 18–45 with recent history of female sex partners were surveyed at...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413635/ https://www.ncbi.nlm.nih.gov/pubmed/37563690 http://dx.doi.org/10.1186/s40834-023-00242-y |
_version_ | 1785087174501203968 |
---|---|
author | Martins, Summer L. Boraas, Christy M. |
author_facet | Martins, Summer L. Boraas, Christy M. |
author_sort | Martins, Summer L. |
collection | PubMed |
description | BACKGROUND: There is high global demand for new methods of male birth control (MBC). However, contemporary evidence regarding men’s method-specific attitudes and their determinants is sparse. METHODS: Non-sterilized cisgender men ages 18–45 with recent history of female sex partners were surveyed at a large community event in the Midwestern US. We examined variation in participants’ willingness to use MBC by method (gel, pill, injection, implant, and vas occlusion), potential side effects, and potential barriers. We estimated crude and adjusted prevalence ratios (aPRs) for associations between participant characteristics and willingness to use ≥ 1 MBC method. RESULTS: Overall, 72% of participants (n = 187; mean age, 29) were very willing to use ≥ 1 MBC method although support for individual methods ranged widely from 62% (pill) to 24% (vas occlusion). In bivariate analysis of sociodemographic and health characteristics, few demonstrated associations with MBC willingness. In a multivariable model, willingness was independently related to age (30–39 vs. 18–29 years old, aPR = 1.24, 95% CI 1.04–1.48) and having ever been tested for HIV (aPR = 1.27, 95% CI 1.07–1.51). Willingness to tolerate side effects was < 10% for most items. The most commonly endorsed barriers to MBC use were high cost (77%) and side effects (66%). CONCLUSIONS: Enthusiasm for MBC was high but waned in the context of potential side effects and barriers. Additional research on MBC attitudes in socioeconomically and culturally diverse populations worldwide is sorely needed. |
format | Online Article Text |
id | pubmed-10413635 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104136352023-08-11 Willingness to use novel reversible methods of male birth control: a community-based survey of cisgender men in the United States Martins, Summer L. Boraas, Christy M. Contracept Reprod Med Research BACKGROUND: There is high global demand for new methods of male birth control (MBC). However, contemporary evidence regarding men’s method-specific attitudes and their determinants is sparse. METHODS: Non-sterilized cisgender men ages 18–45 with recent history of female sex partners were surveyed at a large community event in the Midwestern US. We examined variation in participants’ willingness to use MBC by method (gel, pill, injection, implant, and vas occlusion), potential side effects, and potential barriers. We estimated crude and adjusted prevalence ratios (aPRs) for associations between participant characteristics and willingness to use ≥ 1 MBC method. RESULTS: Overall, 72% of participants (n = 187; mean age, 29) were very willing to use ≥ 1 MBC method although support for individual methods ranged widely from 62% (pill) to 24% (vas occlusion). In bivariate analysis of sociodemographic and health characteristics, few demonstrated associations with MBC willingness. In a multivariable model, willingness was independently related to age (30–39 vs. 18–29 years old, aPR = 1.24, 95% CI 1.04–1.48) and having ever been tested for HIV (aPR = 1.27, 95% CI 1.07–1.51). Willingness to tolerate side effects was < 10% for most items. The most commonly endorsed barriers to MBC use were high cost (77%) and side effects (66%). CONCLUSIONS: Enthusiasm for MBC was high but waned in the context of potential side effects and barriers. Additional research on MBC attitudes in socioeconomically and culturally diverse populations worldwide is sorely needed. BioMed Central 2023-08-10 /pmc/articles/PMC10413635/ /pubmed/37563690 http://dx.doi.org/10.1186/s40834-023-00242-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Martins, Summer L. Boraas, Christy M. Willingness to use novel reversible methods of male birth control: a community-based survey of cisgender men in the United States |
title | Willingness to use novel reversible methods of male birth control: a community-based survey of cisgender men in the United States |
title_full | Willingness to use novel reversible methods of male birth control: a community-based survey of cisgender men in the United States |
title_fullStr | Willingness to use novel reversible methods of male birth control: a community-based survey of cisgender men in the United States |
title_full_unstemmed | Willingness to use novel reversible methods of male birth control: a community-based survey of cisgender men in the United States |
title_short | Willingness to use novel reversible methods of male birth control: a community-based survey of cisgender men in the United States |
title_sort | willingness to use novel reversible methods of male birth control: a community-based survey of cisgender men in the united states |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413635/ https://www.ncbi.nlm.nih.gov/pubmed/37563690 http://dx.doi.org/10.1186/s40834-023-00242-y |
work_keys_str_mv | AT martinssummerl willingnesstousenovelreversiblemethodsofmalebirthcontrolacommunitybasedsurveyofcisgendermenintheunitedstates AT boraaschristym willingnesstousenovelreversiblemethodsofmalebirthcontrolacommunitybasedsurveyofcisgendermenintheunitedstates |